CoChat
Sign Up
Cited by 110Hormonal and reproductive studiesAdrenal Hormones and DisordersAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency

Open access
Corrales, J J, Almeida, M, Burgo, R, Mories, M T, Miralles, J M, Orfao, A·2006·Journal of Endocrinology
DOI 10.1677/joe.1.06779
Open this paper in CoChat — free accountOpen PDF

Abstract

Androgens are considered to have immunomodulatory effects but their cellular mechanisms of action remain largely unknown. In the present study we prospectively analyzed the serial effects of androgen-replacement therapy on both the distribution of peripheral blood lymphocytes, monocytes and dendritic cells as well as on the production of interleukin (IL)-1β, IL-6 and tumor necrosis factor α (TNFα) inflammatory cytokines by circulating monocytes and CD33 myeloid, CD16 and plasmacytoid dendritic cell subsets, the most potent antigen-presenting cells (APCs) in type-2 diabetic men with partial androgen deficiency. Analyses were performed before therapy and at 1, 3, 6 and 12 months after treatment with 150 mg testosterone enanthate every 2 weeks in a group of 13 type-2 diabetic men. Our results show for the first time that testosterone-replacement therapy is associated with a reduction or complete abrogation of spontaneous ex vivo production of IL-1β, IL-6 and TNFα by APCs. Meanwhile, the in vitro production of inflammatory cytokines by these cells after stimulation with lipopolysaccharide plus recombinant human interferon-γ remained unchanged, suggesting that APCs preserve their constitutive machinery to produce inflammatory cytokines under androgen treatment. These results confirm and extend previous observations about the anti-inflammatory effects of androgen therapy on APCs in a new, previously unexplored model of androgen deficiency; namely, aging type-2 diabetic men. A decreased production of inflammatory cytokines by APCs might have important consequences for sex differences in susceptibility to autoimmune diseases, inflammatory response to injury and atheromatosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1677/joe.1.06779

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 56 references

Cited by

Sorted by citations

Items 101–110 of 110

Related

See all

Metadata

Authors
Corrales, J. J., Almeida, M., Burgo, R., Mories, M. T., Miralles, J. M., & Orfao, A.
Affiliations
  • Universidad de Salamanca (ES)
  • Complejo Hospitalario de Salamanca (ES)
ORCID
Venue
Journal of Endocrinology
Publisher
Bioscientifica
Published
2006-06
Volume
189
Issue
3
Pages
595-604
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
DOI
10.1677/joe.1.06779
OpenAlex
W2139503270
Cited by
110
References
56
Citations by year
2026: 5 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 8
FWCI
4.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
testosterone replacement therapy, testosterone enanthate, androgen deficiency, type 2 diabetes, older men, antigen-presenting cells, dendritic cells, monocytes, inflammatory cytokines, IL-1β, interleukin-6, TNF-α, immunomodulation, atheromatosis
MeSH terms
Aged, Androgens, Anti-Inflammatory Agents, Antigen-Presenting Cells, Depression, Chemical, Diabetes Mellitus, Type 2, Humans, Interleukin-1, Lymphocytes, Male, Middle Aged, Testosterone, Tumor Necrosis Factor-alpha, Interleukin-6, Case-Control Studies, Lymphocyte Subsets, Cytokines, Lymphocyte Count, Statistics, Nonparametric, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review